Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Microbiologic and clinical studies with cefuroxime.

H Graber, M Arr, T Magyar

    International Journal of Clinical Pharmacology, Therapy, and Toxicology
    |August 1, 1983
    PubMed
    Summary

    Cefuroxime demonstrates high efficacy against resistant bacterial strains, proving valuable in treating severe infections. This cephalosporin antibiotic was well-tolerated, with a high cure rate in critically ill patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Influence of process temperature and residence time on the manufacturing of amorphous solid dispersions in hot melt extrusion.

    Pharmaceutical development and technology·2022
    Same author

    [Staphylococcus aureus and its genotypes as a mastitis pathogen in dairy cattles - a review].

    Schweizer Archiv fur Tierheilkunde·2019
    Same author

    Virulence gene profiling and ompA sequence analysis of Pasteurella multocida and their correlation with host species.

    Veterinary microbiology·2019
    Same author

    Characterization of Pasteurella multocida strains isolated from human infections.

    Comparative immunology, microbiology and infectious diseases·2019
    Same author

    Exposure-safety and efficacy response relationships and population pharmacokinetics of eslicarbazepine acetate.

    Acta neurologica Scandinavica·2018
    Same author

    Population Pharmacokinetic and Pharmacodynamic Modeling of LY2510924 in Patients With Advanced Cancer.

    CPT: pharmacometrics & systems pharmacology·2017

    Area of Science:

    • Infectious Diseases
    • Pharmacology
    • Microbiology

    Background:

    • Cefuroxime is a lactamase-stable cephalosporin antibiotic.
    • Severe bacterial infections often present challenges for existing therapies.
    • Assessing antibiotic efficacy in critically ill patients is crucial.

    Purpose of the Study:

    • To evaluate the microbiologic and therapeutic efficacy of cefuroxime.
    • To determine cefuroxime's effectiveness in patients with severe bacterial infections.
    • To assess cefuroxime's safety and tolerability profile.

    Main Methods:

    • Disc diffusion method used to test susceptibility of 2532 clinical bacterial isolates.
    • Clinical efficacy assessed in 36 critically ill patients with 43 bacterial infections.
    • Cefuroxime administered at 750 mg and 1500 mg three times daily for an average of 11 days.

    Main Results:

    • High susceptibility rates (80-95%) observed for E. coli, indole-negative Proteus, Klebsiella-enterobacter, and Staphylococcus aureus.
    • 72-74% susceptibility in indole-positive Proteus and Streptococcus B haemolyticus strains.
    • 41 of 43 infections in 34 patients were cured; pathogens eradicated in 34 of 36 infections.

    Conclusions:

    • Cefuroxime exhibits high efficacy against resistant bacterial strains.
    • Cefuroxime is highly valuable in treating severe bacterial infections.
    • Cefuroxime was well-tolerated with minimal side effects, even in patients with penicillin allergy.

    Related Experiment Videos